| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-07 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.25 | 2e-06 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.22 | 7e-06 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.24 | 2e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 2e-05 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |